进行了转化,转化的治疗线(即符合疾病的疾病)从此开始。However, the clinical experts noted that if a patient FL has already been given therapy that is an active regimen for high-grade lymphoma including DLBCL that includes a rituximab-containing regimen with anthracycline (e.g., R-CHOP), especially when treatment is recent, the patients should be regarded as having failed first-line therapy and should be eligible for second-line CAR T-cell therapy.要考虑用于二线CAR T细胞疗法,临床专家指出,患者应像Zuma-7试验中那样将患者暴露于含有蒽环类药物治疗方案(或依托泊苷(如果是蒽环类药物)中,无论是蒽环类药物,无论是不可用的)。•临床专家阐明了复发性疾病的定义